

AMCP eModel is the ultimate tool for communication of health economic models and value evidence. Find out more about this tech partnership and this health economic modeling platform to support the exchange of clinical and economic information between manufacturers and payers.

AMCP partners with FormularyDecisions to enhance information sharing and formulary decision-making by creating a platform for current, credible, and compliant information exchange between life science companies and active, qualified healthcare decision-makers.
Featured






-
Health Information Technology Resources
-
Digital Therapeutics Resources
-
Health Disparities Resources
-
Value-Based Contracts Resources
Meetings Proceedings & Findings
View More


Latest News & Resources

Diabetes technology is the hardware, devices, and software that people with diabetes use to help manage their condition. Diabetes technology has expanded to include complex devices that both monitor blood sugar and deliver insulin. The American Diabetes Association now recommends use of continuous glucose monitoring (CGM) in individuals with both type 1 and type 2 diabetes. Rapid change in the diabetes technology landscape may lead to access barriers that can impact health plan programs, necessitating appropriate coverage policies.

Partnership Forum: Participants discussed how digital therapeutics with web and designed based applications are emerging as a means to treat conditions by engaging people to improve health and wellness.

The AMCP Health Disparities Advisory Group conducted a landscape assessment to understand the role of managed care pharmacy in identifying and addressing health care disparities. Explore their findings and discover opportunities to dismantle inherent health disparities by downloading the assessment.

Host Fred Goldstein invites Jim Hopsicker, AMCP President & Vice President, Health and Pharmacy Management at MVP Health Care, Inc., and Susan Cantrell, AMCP CEO, to discuss the state of AMCP Priorities.
This article highlights five myths about treatment for OUD, provides context regarding current guidance, and offers suggestions for how managed care organizations (MCOs) can support care for patients with addiction through a chronic health model.

This advisory group was active from April 2021-March 2022.

The world of prescription drug care and coverage can be complicated. Read AMCP CEO Susan Cantrell’s blog on AMCP’s inaugural “Access, Affordability, & Outcomes: The Value of Managed Care Pharmacy” annual report to learn how we’re making it more understandable

Managed care pharmacy and prescription drug coverage is a growing part of the American health care sector. AMCP launched the annual Access, Affordability, and Outcomes report to raise awareness of the existence, prevalence, and importance of managed care pharmacy.
This sponsored webinar reviews DHHS guidelines for regimen initiation and optimization, and 5-year efficacy and safety in treatment-naive adults.
This non-promotional, sponsored webinar reviewed health plan best practice recommendations for continuous glucose monitoring with an impressive panel of clinical and managed care experts.

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up!, sits down with Marissa Schlaifer and Billy West, AMCP Distinguished Service Award recipients, to discuss the role of AMCP in their careers.

Use of appropriate medication regimens, regardless of cost, may help to improve patients’ conditions, improve quality of life, and lower other health care costs.